United States · FDA National Drug Code directory
Ryplazim
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 70573-099_cbc275fd-d97b-4320-ba27-80752d592572
- Product NDC
- 70573-099
- Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Composition / generic term
- plasminogen
- Labeler
- Kedrion Biopharma, Inc.
- Marketing category
- BLA
- Marketing start / end (source format)
- 20210604
- Source listing expiry
- 20261231
Source-listed ingredients
- PLASMINOGEN — 68.8 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL, GLASS in 1 CARTON (70573-099-02) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, GLASS (70573-099-01) · 70573-099-02
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →